Tech Company Financing Transactions
Greenstone Biosciences Funding Round
Greenstone Biosciences, operating out of Palo Alto, received investment capital from JDRF T1D Fund.
Transaction Overview
Company Name
Announced On
8/19/2026
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to develop a T1D-derived islet cell platform, create induced pluripotent stem cells (iPSCs) from T1D patients, build 3D pancreatic islet organoids, and apply multi-omics technologies to examine how insulin-producing ß cells respond to inflammation, metabolic stress, and protective therapies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Stanford Research Park, 3160 Porter Drive 140
Palo Alto, CA 94304
USA
Palo Alto, CA 94304
USA
Phone
Website
Email Address
Overview
Greenstone Biosciences is a Stanford Research Park--based biotech innovator at the nexus of regulatory change and technological advancement. Founded on the belief that NAMs--and human-relevant models--are reshaping the future of medicine. Our drug discovery platform s fueled by an exceptional data trove, augmented with artificial intelligence/machine learning, and grounded by stem cell biology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lip-Bu Tan
Chief Financial Officer
Amit Parikh
Co-Founder
Jade Chao
Co-Founder
Joseph Wu
VP - R & D
Paul Pang
Browse more venture capital transactions:
Prev: 8/18/2026: Thea Energy venture capital transaction
Next: 8/19/2026: trutility venture capital transaction
Share this article
News on VC Transactions
We report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs